Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: An open-label trial

Eduardo Leiderman, Ilana Zylberman, Stephen R. Zukin, Thomas B. Cooper, Daniel C. Javitt

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)213-215
Number of pages3
JournalBiological Psychiatry
Volume39
Issue number3
DOIs
StatePublished - Feb 1 1996
Externally publishedYes

Keywords

  • Glutamate
  • NMDA receptor
  • Phencyclidine (PCP) treatment
  • Positive and Negative Syndrome Scale (PANSS)

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this